UoH start-up ties up with GenepoweRx
Hyderabad: Transcell Oncologics, an ASPIRE-TBI incubatee at the University of Hyderabad (UoH), announced a tie-up and on-boarding of GenepoweRx, a bioinformatics engine, for personalising medical procedures. Transcell developed a vertical named Hemato into adult stem cell technology translation for imparting hematopoietic stem cell transplantation procedure. The tie-up enables Transcell to offer Hemato’s Pregen genomics medicine […]
Updated On - 24 November 2021, 07:18 PM
Hyderabad: Transcell Oncologics, an ASPIRE-TBI incubatee at the University of Hyderabad (UoH), announced a tie-up and on-boarding of GenepoweRx, a bioinformatics engine, for personalising medical procedures.
Transcell developed a vertical named Hemato into adult stem cell technology translation for imparting hematopoietic stem cell transplantation procedure. The tie-up enables Transcell to offer Hemato’s Pregen genomics medicine prescription for managing any diseases/s predisposition predicted, the UoH said on Wednesday.
The next-gen in-silico tools integrated into the Hemato workflow offer solutions to health-conscious families and families with disease history in making data-based informed decisions managing and caring for their health, it said.
“This working relationship with the Genomics medicine practitioners brings together innovation and execution personalising technology to provide superior productized services,” said Subhadra Dravida, CEO and founder of Transcell in a joint statement along with Dr Vinayender Tulla, Director, Transcell.
“By pairing bioinformatics tools, the relevant downstream clinical practice expertise with Transcell’s validated cell technology, we are excited to support their differentiated and meaningful offerings,” said Dr Kalyan Uppaluri of GenepoweRx.
Now you can get handpicked stories from Telangana Today on Telegram everyday.
Click the link to subscribe. Click to follow Telangana Today Facebook page and Twitter .